indalpine has been researched along with 3,4-dihydroxyphenylglycol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benkelfat, C; Dennis, T; Garreau, M; Loo, H; Poirier, MF; Scatton, B; Sechter, D; Vanelle, JM | 1 |
Benkelfat, C; Dennis, T; Lôo, H; Olié, JP; Poirier, MF; Scatton, B; Vanelle, JM | 1 |
Benkelfat, C; Dennis, T; Loo, H; Olie, JP; Poirier, MF; Scatton, B; Susini de Luca, H; Vanelle, JM | 1 |
3 other study(ies) available for indalpine and 3,4-dihydroxyphenylglycol
Article | Year |
---|---|
[Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol].
Topics: Adult; Antidepressive Agents; Brain; Depressive Disorder; Dexamethasone; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Piperidines | 1985 |
Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
Topics: Adult; Aged; Anthracenes; Depression; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Piperidines | 1986 |
Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative results.
Topics: Brain; Depressive Disorder; Dexamethasone; Glycols; Humans; Hypothalamo-Hypophyseal System; Maprotiline; Methoxyhydroxyphenylglycol; Norepinephrine; Piperidines; Pituitary-Adrenal System; Random Allocation | 1985 |